7/8 Small caps where institutions bought the biggest share of the company in one quarter:
TaskUs 38.6% of its value, FuelCell Energy 32.5%, Q32 Bio 31.6%, PMV Pharmaceuticals 29.5%. Five of the top ten are biotech.
1
291
6/8 Below the mega-caps, conviction showed up in healthcare.
11 of the 21 stocks passing our Heavy Institutional Buying filter are healthcare, mostly biotech: Silence Therapeutics +$270M with 29% more funds holding it, Pulse Biosciences +$238M with 35% more.
1
13
1/8 Where did institutional money go in Q3 2026? We read every 13F filing for the quarter ended Sept 30: 8,810 managers.
Technology took the most, +$91.2B. Financials and consumer staples were net sold.
Full report at the bottom.
1
557
Duquesne Family Office LLC - Druckenmiller top 10 new positions
Q: 2026-09-30
via finradar.ai/filer/duquesne-f…
1
798
Happy 13F day! Track every hedge fund's Q3 moves live on FinRadar.
Black Friday deal: 25% off Premium, code THANKSGIVING25. Ends Nov 30.
finradar.ai/x
Enjoy our full financials, ratios, segments tools and charts, and our revamped website!
615
TIGER GLOBAL MANAGEMENT LLC - TOP 10 HOLDINGS
Q: 2026-09-30
via finradar.ai/filer/tiger-glob…
Avoro Capital Advisors LLC - NEW POSITIONS
Q: 2026-09-30
via finradar.ai/filer/avoro-capi…
13F Filing - AMAZON COM INC. No position changes
finradar.ai/filer/amazon-com… #13F
680
🇧🇷 Brazilian Bank ADRs seeing Insider Net Buying lately:
$BBD is in a completely different league — Alvarez Rubens Aguiar alone bought $29,494,260 on Sept. 1 (1,698,000 shares @ R$17.37) via an indirect fund. Denise Aguiar separately deployed 5 large tranches on Aug. 31 totaling ~$20M+ in preference shares. This is institutional-scale insider conviction.
$BSBR CEO Leao's accumulation from June 2–16 ($2.85M+ in open market buys) remains the highlight, supported by 20+ officers buying in Q3.
$ITUB Real cash buys total only ~$1.1M.






















